The Pancrelipase Tablets, cataloged under National Stock Number 6505-01-101-8922, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Erbamont Inc Adria Laboratories Div. Government technical data includes 5 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-101-8922 |
| Primary Part Number | NDC00013-2001-19 |
| Item Name | Pancrelipase Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Erbamont Inc Adria Laboratories Div |
| Status | ACTIVE |
| Administration | ORAL |
| Primary Container Content Quantity | 250.000 TABLETS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 30000.000 USP UNITS AMYLASE ACTIVE INGREDIENT AND 11000.000 USP UNITS LIPASE ACTIVE INGREDIENT AND 30000.000 USP UNITS PROTEASE ACTIVE INGREDIENT |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| NDC00013-2001-19 PRIMARY | Erbamont Inc Adria Laboratories Div (USA) |
| Reference | Meaning |
|---|---|
| ILOZYME | 5/1 Secondary reference Erbamont Inc Adria Laboratories Div |
NSN 6505-01-101-8922 is a Pancrelipase Tablets, manufactured by Erbamont Inc Adria Laboratories Div, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-101-8922 has 1 manufacturer part number on file: NDC00013-2001-19 (Erbamont Inc Adria Laboratories Div).
Key specifications for NDC00013-2001-19: Administration: ORAL; Primary Container Content Quantity: 250.000 TABLETS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 5 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.